The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Food allergy, or the aggressive immune system reaction following the consumption of a certain food or food ingredient, ...

Food allergies can be life-threatening due to the rapid and exaggerated immune response. While mucosal mast cells (MMCs) are ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

China Emerging Key Player in Development Of Gamma Delta T Cell Cancer Therapy Says KUICK RESEARCHDelhi, Jan. 29, 2025 (GLOBE ...

This study compares immune proteins and bioactive peptides in cow and camel milk, highlighting camel milk's lower allergenic ...

Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...